In insulin-sensitive cells, such as adipocytes and skeletal muscle, the activation of phosphoinositide 3-kinase (PI 3-kinase) is thought to be critical in allowing insulin to stimulate both the uptake of glucose and the translocation of a specialized glucose transporter, GLUT4, to the plasma membrane. However, the downstream mediators that couple PI 3-kinase to GLUT4 translocation are still not known. Recent studies have shown that the GTPbinding protein Rac mediates some of the biological effects of PI 3-kinase, and these findings,have led to the suggestion that Rac may be a common mediator for a variety of responses mediated by PI 3-kinase. To determine whether Rac couples PI 3-kinase to glucose uptake in adipocytes, we produced 3T3-L1 cells expressing either a constitutively active Racl (V12 Racl, containing a valine residue at position 12) or a dominant-inhibitory Racl (N17 Racl, containing an asparagine residue at position 17). Results: The stable expression of both V12 Racl and N17 Racl led to observable phenotypes in 3T3-L1 cells; expression of V12 Racl resulted in constitutive formation of lamellipodia and constitutive activation of the cJun-N-terminal kinase (NK), whereas expression of N17 Racl inhibited the insulin-stimulated formation of lamellipodia. However, neither basal glucose uptake nor insulin-stimulated glucose uptake was affected by the expression of either mutant Rac protein. In addition, expression of V12 Racl did not reverse the inhibition of insulin-stimulated glucose uptake caused by the PI 3-kinase inhibitor wortmannin. Conclusions: These findings provide direct evidence that PI 3-kinase does not use Rac to couple the insulin receptor to glucose uptake in adipocytes. Furthermore, the finding that Rac does not mediate glucose uptake in response to insulin is consistent with the idea that PI 3-kinase couples to a variety of different effector molecules in cells, and suggests that some of the specificity in the biological responses elicited by PI 3-kinase may be mediated by the activation of different effector molecules.
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Background
Insulin maintains blood glucose levels by stimulating the uptake of excess glucose into insulin-sensitive fat and muscle cells [1, 2] . To this end, insulin stimulates the translocation of a specialized glucose transporter, GLUT4, from an intracellular compartment to the plasma membrane [1, 2] . Only adipose tissue and muscle express GLUT4 and, as a result, these tissues are primarily responsible for regulating blood glucose levels after absorption of glucose from the gut.
The early intracellular signaling events linking the insulin receptor to GLUT4 translocation and glucose uptake in fat and muscle are now beginning to be understood. Ligand binding results in receptor autophosphorylation and activation of the intrinsic tyrosine-kinase domain of the insulin receptor [3, 4] . The active insulin receptor tyrosine-phosphorylates a family of 180-190 kDa proteins, including the insulin receptor substrates IRS-1 and IRS-2, which couple the receptor to downstream signaling pathways by serving as 'docking proteins' for signaling molecules that have Src homology 2 (SH2) domains [5] . PI 3-kinase is one of the SH2-domain-containing signaling molecules that is activated by binding to IRS-1 and IRS-2 [6] , and is likely to be critical for coupling the insulin receptor to glucose uptake and GLUT4 translocation. This suggestion is supported by the findings that IRS-1 gene 'knockout' mice are resistant to insulin, and that pharmacological inhibitors of PI 3-kinase block glucose uptake in adipocytes [7] [8] [9] [10] . PI 3-kinase catalyzes phosphorylation of the 3-OH group of phosphatidylinositol (PI) [11] [12] [13] . Activation of PI 3-kinase by the insulin receptor leads to a rapid increase in the formation of intracellular PI(3,4,5)-trisphosphate (PI(3,4,5)-P 3 ) [14, 15] . It is thought that PI(3,4,5)-P 3 functions directly as a second messenger to mediate cellular responses [13, 15, 16] . Although several downstream targets of PI 3-kinase have now been identified [17] [18] [19] , the mechanism whereby PI 3-kinase couples the insulin receptor to glucose uptake and GLUT4 translocation in insulin-sensitive cells is still not known.
Several lines of experimental evidence have identified the small GTP-binding protein Rac as one of the targets for PI 3-kinase activation [19] . First, activation of a variety of diverse cellular processes requires the activation of both PI 3-kinase and Rac. For example, both Rac and PI 3-kinase are likely to be involved in superoxide generation in neutrophils and regulated secretion in mast cells and basophils [20] [21] [22] [23] [24] . In addition, activation of both Rac and PI 3-kinase is required for growth factors, such as insulin and platelet-derived growth factor (PDGF), to induce actin reorganization, which leads to the formation of lamellipodia [25] [26] [27] .
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The second observation implicating Rac as a mediator of PI 3-kinase action comes from studies demonstrating that PI 3-kinase lies upstream of Rac on a signaling pathway stimulated by receptor tyrosine kinases. It has been shown that treatment of cells with various PI 3-kinase inhibitors blocks the formation of lamellipodia induced by PDGF, and that the ability of PI 3-kinase inhibitors to block lamellipodial formation is antagonized by the expression of a constitutively active Rac protein [25, 26] . In addition, PI 3-kinase has been shown to mediate the increase in Rac bound to GTP (the active form of Rac) in cells stimulated with PDGF [26] . Thus, the finding that PI 3-kinase sits upstream of Rac on a signaling pathway has led to the suggestion that Rac is a common mediator of the various biological effects that follow PI 3-kinase activation.
With respect to a possible role for Rac in mediating glucose uptake by insulin, previous studies have also shown that activation of one or more GTP-binding protein(s) in adipocytes by GTP-yS (a non-hydrolyzable analogue of GTP) stimulates GLUT4 translocation [28] . This finding, coupled with the demonstration that PI 3-kinase activates Rac and is required for GLUT4 translocation, raises that possibility that both GTP-yS and PI 3-kinase stimulate GLUT4 translocation by activating Rac. Although the mechanism whereby Rac could couple PI 3-kinase to glucose transport is not clear, reorganization of the actin cytoskeleton is one possibility. Alternatively, Rac might couple PI 3-kinase to GLUT4 translocation by activating a kinase cascade which then activates GLUT4 translocation; Rac has been shown to trigger a kinase cascade resulting in activation of the cJun-N-terminal kinase NK) [29, 30] .
We wanted to determine whether Rac mediates insulinstimulated glucose uptake and GLUT4 translocation in an insulin-sensitive 3T3-L1 adipocyte cell line. We reasoned that, if activation of Rac by PI 3-kinase is necessary for PI 3-kinase to stimulate glucose uptake, inhibition of Rac should block insulin-stimulated glucose transport in adipocytes. In this paper, we show that although expression of the dominant-inhibitory N17 Racl caused a marked reduction in insulin-stimulated actin reorganization, as assessed by the formation of lamellipodia, insulinstimulated glucose uptake was not inhibited. Moreover, expression of the constitutively active V12 Racl did not antagonize the ability of the PI 3-kinase inhibitor wortmannin to block glucose uptake by insulin. These findings indicate that Rac is not on a signaling pathway linking the insulin receptor to glucose uptake.
causes constitutive activation, whereas N17 Racl has an asparagine residue at position 17, which has been shown to have a dominant-inhibitory function, inhibiting endogenous Rac [32] . Geneticin-resistant pools and clones of 3T3-L1 cells were isolated, and overexpression of the Rac proteins was determined in cell lysates by immunoblotting using the 9E10 antibody, which recognizes the Myc-epitope tag ( Fig. 1) [33] . The levels of the Rac proteins in the transfected cells, relative to those of endogenous Rac, were not determined because good anti-Rac antibodies were not available.
V12
Racl causes the constitutive formation of lamellipodia and activation of JNK in serum-starved 3T3-L1 cells Expression of V12 Rac has previously been shown to cause reorganization of the actin cytoskeleton, leading to the constitutive formation of lamellipodia [32] . To verify that expression of V12 Racl has a meaningful biological effect in 3T3-L1 cells, we measured lamellipodial formation in 3T3-L1 cells expressing V12 Racl. Serumstarved control and V12 Racl-expressing 3T3-L1 fibroblasts were either not stimulated or stimulated with 100 nM insulin for 5 minutes, and lamellipodial formation was assessed by immunofluorescence microscopy using FITC-phalloidin. Only a few membrane ruffles and lamellipodia were detected in serum-starved parental 3T3-L1 cells, and the percentage of cells expressing lamellipodia increased markedly after insulin stimulation (Figs 2a,c). In contrast to control cells, however, most serum-starved 3T3-L1 fibroblasts expressing V12 Racl constitutively formed lamellipodia in the absence of insulin stimulation (Figs 2a,c) , and exhibited circular membrane ruffles possibly as a result of high levels of Rac activity [26] .
In addition, although the PI 3-kinase inhibitor wortmannin blocked the formation of lamellipodia in insulin-stimulated control cells, the expression of V12 Racl antagonized this inhibitory effect (Fig. 2a) . To confirm further that Rac was activated in 3T3-L1 cells
Results
Stable 3T3-L1 cell lines overexpressing V12 Racl and N17 Racl 3T3-L1 cells were infected with a retroviral construct that encoded either Myc-epitope-tagged V12 Racl or N17 Racl [31, 32] and conferred resistance to geneticin. V12 Racl has a valine residue at position 12, which fibroblasts. 3T3-L1 cells were infected with retroviruses encoding either V12 Racl or N17 Racl. Geneticin-resistant pools and clonal cell lines were isolated, lysed and immunoblotted using the anti-Myc antibody 9E10.
expressing V12 Racl, we measured JNK activity; V12 Racl has previously been shown to activate a kinase cascade leading to JNK activation [29, 30] . In comparison to parental cells, JNK activity was markedly elevated in serum-starved 3T3-L1 cells expressing V12 Racl (Fig.  2b) . Thus, the expression of V12 Racl in 3T3-L1 cells results in the activation of a variety of biological responses that are normally mediated by activated Rac proteins.
VI 2 Racl does not reverse wortmannin-induced inhibition of insulin-stimulated glucose uptake
To determine whether Rac is responsible for coupling PI 3-kiinase to glucose uptake in insulin-sensitive tissues, we determined whether expression of V12 Racl prevented wortmannin from inhibiting glucose uptake in adipocytes.
When used at low concentrations (< 100 nM), wortmannin has been shown to be a relatively specific inhibitor of PI 3-kinase, and to block insulin-stimulated glucose uptake in 3T3-L1 adipocytes [10, 21] . We reasoned that, if PI 3-kinase stimulates glucose uptake by activating Rac, expression of an activated V12 Racl protein should antagonize the ability of wortmannin to block glucose uptake in 3T3-L1 adipocytes.
Pools and clones of V12 Racl-expressing 3T3-L1 fibroblasts were then differentiated into adipocytes, which were assayed for glucose uptake in response to insulin stimulation in the presence and absence of wortmannin. Overexpression of V12 Racl did not interfere with the differentiation of 3T3-L1 fibroblasts into adipocytes, as determined by the staining of differentiated adipocytes with oil red O and the analysis of GLUT4 expression by immunoblotting (data not shown). We did not detect a difference in glucose uptake between parental control and V12 Racl-expressing adipocytes; basal and insulin-stimulated glucose uptake were similar in parental adipocytes and those expressing active V12 Racl (Fig. 3) . Moreover, wortmannin treatment inhibited glucose uptake in both Fig. 2 . Expression of V12 Racl causes the constitutive formation of lamellipodia and activation of JNK in 3T3-L1 cells. Pools of V12 Racl -expressing 3T3-L1 cells or control cells were serumstarved for 16 h in Dulbeco's modified Eagle's medium (DMEM) containing 0.2 % fetal bovine serum (FBS). Cells were then either not stimulated or stimulated with 100 nM insulin, fixed and lamellipodia were visualized using FITC-phalloidin as described in Materials and methods. In (a) 100 cells were evaluated for lamellipodial formation in two separate experiments. To determine the effect of wortmannin on the formation of lamellipodia, cells were incubated with wortmannin 5 min prior to stimulation with insulin. (b) Cell lysates (100 ,ug) prepared from either control or V12 Racl-expressing 3T3-L1 cells were incubated with 10 ,ug fusion protein, made up of glutathione-S-transferase and cjun (GST-cJun), coupled to glutathione-agarose beads. After washing, an in vitro kinase reaction was performed by incubating the beads in 50 ,al kinase buffer containing 15 ICi y-[ 3 2 PIATP. After incubation for 20 min at 30 C, the reaction was stopped by boiling in sample buffer, and the reaction products were separated by SDS-PAGE (12 % gel) and phosphorylated GST-cJun was visualized by autoradiography. (c) Cells prepared as in (a).
control and V12 Racl-expressing adipocytes to a similar extent (Fig. 3) ; it also inhibited basal glucose uptake to a similar extent (data not shown). The finding that basal glucose uptake is similar in control and V12 Racl-expressing cells indicates that activation of Rac is not, by itself, sufficient to stimulate the relocalization of GLUT4 to the plasma membrane. In addition, the inability of V12 Racl to antagonize the ability of wortmannin to inhibit glucose uptake by insulin indicates either that Rac does not couple PI 3-kinase to glucose transport in adipocytes or that PI 3-kinase must activate other signaling molecules, in addition to Rac, in order to stimulate glucose uptake.
N17 Racl does not inhibit glucose uptake in 3T3-L1 adipocytes
Having established that Rac activation is not sufficient for insulin to stimulate glucose uptake in adipocytes, we asked whether Rac is even required on this pathway. We assayed glucose uptake in 3T3-L1 cell lines expressing N17 Racl; if activation of Rac is critical for glucose uptake, and if insulin does not activate signaling pathways that are redundant to Rac function, expression of the dominant-inhibitory N17 Racl should inhibit insulinstimulated glucose uptake. In contrast to the expression of V12 Racl, the expression of N17 Racl in 3T3-L1 cells was lower and tended to decrease with the passage of cells in -culture, probably because of the inhibitory effect of N17 Racl on cell growth [31] ; N17 Racl-expressing 3T3-L1 fibroblasts grew more slowly and to lower saturation density then control cells (data not shown). Nevertheless, early passaged geneticin-resistant pools and clonal cell lines of 3T3-L1 cells expressing N17 Racl were obtained, in which the induction of lamellipodia by insulin was inhibited by 60-80 % (Fig. 4) . We were unable to demonstrate inhibition of JNK activation by N17 Racl in 3T3-L1 adipocytes because insulin did not activate JNK in these cells. As with 3T3-L1 cells expressing V12 Racl, expression of N17 Racl did not inhibit the differentiation of 3T3-L1 fibroblasts into adipocytes (data not shown). Moreover, although expression of N17 Racl significantly inhibited lamellipodial formation in response to insulin, insulin-stimulated glucose uptake was similar in control and N17 Racl-expressing adipocytes. Thus, the activation of Rac is not even necessary for insulin to stimulate glucose uptake and GLUT4 translocation in adipocytes.
Discussion
Several studies have now implicated both IRS-1 and PI 3-kinase as important signaling molecules linking the insulin receptor to glucose uptake and GLUT4 translocation [7] [8] [9] [10] . Although it is well established that PI 3-kinase is activated by binding to IRS-1 in insulin-stimulated cells [5] , the events downstream from PI 3-kinase that mediate GLUT4 translocation are still not known. A major challenge has been to understand the mechanism whereby PI 3-kinase couples the insulin receptor to glucose uptake. In this report, we show that the GTP-binding protein Rac, which is a prime candidate for an effector molecule that mediates cellular responses involving PI 3-kinase, does not mediate insulin-stimulated glucose uptake in adipocytes.
It is unlikely that our inability to demonstrate an effect of the mutant Rac proteins on glucose uptake is due to inadequate expression of these proteins in 3T3-L1 cells. We observed the expected phenotypic changes after expression of the constitutively active V12 Racl and the dominant-inhibitory N17 Racl in 3T3-L1 cells; expression of V12 Racl led to the constitutive formation of lamellipodia and the activation of JNK, whereas expression of N17 Racl inhibited lamellipodia formation in response to insulin. In addition, expression of V12 Racl prevented wortmannin from blocking the induction of lamellipodia by insulin.
Any model of how PI 3-kinase couples the insulin receptor to glucose transport must account for PI 3-kinase mediating specific cellular responses following its activation by different receptors. Although the most tyrosine kinase and cytokine receptors activate PI 3-kinase, only insulin and insulin-like growth factor-1 (IGF-1) effectors following its activation by different receptors, one possibility is that individual receptors may localize an active PI 3-kinase to specific intracellular compartments, thereby resulting in the modification of distinct pools of PI by PI 3-kinase. The finding that PI(3,4,5)-P 3 is unlikely to diffuse throughout the cell would suggest that it functions primarily in the intracellular location where it is made [19] .
In addition, it is possible that the specificity of the responses elicited by PI 3-kinase is also determined in combination with PI 3-kinase-independent signaling pathways that are activated by different receptors. We think it likely that at least one other signaling pathway, in addition to that involving PI 3-kinase, is necessary for insulin to stimulate glucose uptake and GLUT4 translocation: we found, for example, that activation of PI 3-kinase by the IL-4 receptor is, in itself, not sufficient to stimulate glucose uptake and GLUT4 translocation in L6 myoblasts [34] . We predict that active PI 3-kinase localizes to the same intracellular compartment in cells stimulated with insulin and IL-4, so abnormal localization of the active PI 3-kinase is unlikely to account for the failure of IL-4 to stimulate glucose uptake. In contrast to other receptors, both the IL-4 and insulin receptors use tyrosine-phosphorylated IRS-1 as an intermediate in activating PI 3-kinase [35] , and tyrosine-phosphorylated IRS-1 has been shown to localize to the same intracellular compartment as the active PI 3-kinase in insulinstimulated cells [36] . Thus, it now appears that understanding the mechanism whereby the insulin receptor couples to glucose transport will require not only an understanding of the role of PI 3-kinase in mediating glucose uptake by insulin but also the identification of the other signaling pathway(s) activated by insulin that couple to this response. Fig. 4 . Expression of N17Rac1 inhibits insulin-stimulated lamellipodial formation, but not glucose uptake, in 3T3-L1 adipocytes. (a) Cells were either not stimulated or stimulated with 100 nM insulin, and lamellipodia formation was determined as described in Figure 2a. (b) Glucose uptake in 3T3-L1 adipocytes expressing N17 Racl was assayed as described in Fig. 3. have, thus far, been shown to stimulate GLUT4 translocation in insulin-sensitive cells. We have found that activation of PI 3-kinase by receptors other then those for insulin or IGF-1 does not stimulate GLUT4 translocation [34] . Thus, the finding that Rac mediates some of the responses involving PI 3-kinase, such as lamellipodial formation, but does not mediate insulin-stimulated glucose uptake, is consistent with the idea that some of the specificity in the biological responses elicited by PI 3-kinase may be mediated through its activation of different effector molecules. Although it is still not clear how PI 3-kinase is directed to couple to specific targeted Although PI 3-kinase is probably one of the intracellular signaling molecules responsible for coupling the insulin receptor to GLUT4 translocation and glucose uptake in insulin-sensitive cells, it is important to point out that studies linking PI 3-kinase to glucose transport are based mostly on the use of pharmacological inhibitors of PI 3-kinase. Although these compounds appear to be specific for PI 3-kinase when used at appropriate concentrations, it may be premature to conclude that they do not inhibit other molecules that are critical for glucose uptake. In addition, a growing family of PI 3-kinases, distinct from the heterodimeric p85-p110 PI 3-kinases that are activated by binding to IRS-1 in insulin-stimulated cells, have been identified and have been found to be inhibitable by wortmannin [37] [38] [39] [40] . The roles of these other PI 3-kinases in mediating cellular responses are still not known. It is clear, therefore, that a full understanding of the biological responses mediated by PI 3-kinases will require not only the identification of downstream targets for PI 3-kinase but also the use of more specific inhibitors of the different PI 3-kinases, in order to determine which responses are mediated by the different family members.
Conclusions
secondary anti-mouse antibody and visualized using enhanced chemiluminescence.
The finding that Rac couples PI 3-kinase to some biological responses has led to the suggestion that Rac is the common mediator for a variety of responses mediated by PI 3-kinase. In this report, we have shown that Rac does not couple PI 3-kinase to glucose uptake in an insulin-sensitive adipocyte cell line, so Rac does not mediate all of the cellular responses stimulated by PI 3-kinase. PI 3-kinase must mediate different cellular responses following its activation by different receptors; our results suggest that some of the specificity in the biological responses elicited by PI 3-kinase may arise through the activation of a variety of different effector molecules.
Materials and methods
Cell lines, expression vectors and the production of retroviruses
Murine 3T3-L1 cells were maintained in DMEM containing 10 % calf serum (Gibco, BRL). Two days after reaching confluence, 3T3-L1 fibroblasts were differentiated into adipocytes by incubation for 3 days in DMEM containing 10 % FBS, 1 J.M insulin, 0.5 mM 3-isobutyl-1-methylxanthine and 1 .M dexamethasone [9] . Experiments on adipocytes were performed 10-20 days after differentiation. To overexpress V12 Racl and N17 Racl in 3T3-L1 cells, the DNA sequence encoding the Myc epitope fused to either the sequence encoding V12 Racl or that encoding N17 Racl was subcloned into the retroviral vector SRox [31, 32, 41] . Helper-free infectious retrovirus was produced by transiently transfecting the Rac constructs into the retroviral packaging cell line BOSC 23 using calcium phosphate precipitation, as described [42] . Retroviruses expressing V12 Racl or N17 Racl were used to infect 3T3-L1 fibroblasts and geneticin-resistant pools and clonal cell lines were isolated. Overexpression of the Rac constructs was determined by immunoblotting using the anti-Myc antibody 9E10 [33] .
Glucose uptake
Glucose uptake was assayed using 2-deoxy-D- [ 3 H]glucose, as described previously [43] . 3T3-L1 cells were differentiated in 12-well plates as described above, and glucose uptake was assayed on cells 10-20 days after differentiation. After overnight starvation, cells were either not stimulated or stimulated with 100 nM insulin for 20 min at 37 C. Cells were then washed twice with Hepes buffer (20 mM Hepes pH 7.4, 140 mM NaCI, 5 mM KCI, 2.5 mM MgSO 4 and M CaC12), and then incubated with transport solution (Hepes buffer containing 0.5 l.Ci ml-' 2-deoxy-D-[3H]glucose and 10 p.M 2-deoxy-D-glucose) for 10 min. Cells were washed three times with ice-cold PBS and solubilized in 0.05 N NaOH. Uptake of 2-deoxy-D-[ 3 H]glucose was determined by scintillation counting. The total amount 2-deoxy-D-glucose in the cells was determined from the uptake of 2-deoxy-D- [ 3 H]glucose and was expressed in terms of total cell protein. Protein concentration was determined using the Bradford method [44] . To determine the effect of wortmannin on glucose uptake, adipocytes were incubated with wortmannin 5 min prior to stimulation with insulin and glucose uptake was determined as described above.
Cell lysis and immunoblotting
Cell lysis and immunoblotting were performed as described previously [45] . The anti-Myc antibody was detected using a
Analysis of lamellipodia formation in 3T3-L 1 cells expressing V12 RacI or N17 Racl
3T3-L1 fibroblasts infected with control virus, or cells overexpressing V12 Rac or N17 Rac , were serum-starved for 16 h in DMEM containing 0.2 % FBS. Cells were then either not stimulated or stimulated with 100 nM insulin, fixed for 10 min in 3.5 % formaldehyde and permeabilized with 0.2 % Triton X-100. Actin filaments were detected using fluorescein isothiocyanate-labeled phalloidin (FITC-phalloidin), as previously described [32, 46] . To determine the effect of wortmannin on membrane ruffling, appropriate samples were pretreated with wortmannin for 5 min prior to stimulation with insulin.
Protein kinase assay
Lysates (100 .Lg) prepared from V12 Racl-infected 3T3-L1 fibroblasts and control cells were incubated with 10 .Lg GST-cJun (containing amino acids 1-223 of cJun) coupled to glutathione-agarose beads for 2 h at 4 C, as described [47] . After washing the beads three times with lysis buffer and once with kinase buffer (20 mM Hepes pH 7.4, 20 mM MgC1 2 , 10 mM NaF, 20 mM 3-glycerophosphate, 20 mM PNPP, 1 mM DTT and 0.2 mM orthovanadate), the kinase reaction was started by incubating the beads in 50 p.l kinase buffer containing 20 p.M cold ATP and y-[ 32 P]ATP (15 ILCi per sample). After incubation at 30 C for 20 min, the reaction was terminated by boiling the mixtures in sample buffer for 5 min and the reaction products were separated by SDS-PAGE on 12 % gels.
